{"abnormal loss of weight": 4.83, "acute graft versus host disease": 10.59, "adenovirus infection": 14.27, "adrenal insufficiency": 16.15, "adrenal suppression": 62.8, "adrenocortical insufficiency acute": 23.19, "adverse drug reaction": 4.93, "anaphylactoid reaction": 3.29, "aphthous ulcer": 2.24, "aspergillus infection": 10.73, "asphyxia": 14.4, "aspiration": 9.46, "asthma": 22.98, "asthmatic crisis": 10.11, "bk virus infection": 9.6, "blood calcium increased": 13.38, "blood corticotrophin decreased": 50.13, "blood immunoglobulin e increased": 45.51, "blood lactic acid increased": 30.63, "blood potassium decreased": 8.78, "blood test abnormal": 7.06, "body height decreased": 6.27, "breath sounds abnormal": 37.55, "bronchiectasis": 15.92, "bronchitis": 3.59, "bronchopulmonary aspergillosis": 4.17, "bronchopulmonary aspergillosis allergic": 123.74, "bronchospasm": 5.72, "candida infection": 2.47, "chest discomfort": 4.13, "chest x-ray abnormal": 36.89, "chronic obstructive pulmonary disease": 6.26, "chronic sinusitis": 91.97, "colitis": 7.76, "colitis microscopic": 19.38, "colitis ulcerative": 9.17, "condition aggravated": 2.24, "constipation": 2.02, "cortisol decreased": 25.99, "cough": 3.1, "crohn's disease": 8.21, "cryptococcosis": 20.07, "cushing's syndrome": 75.16, "cushingoid": 43.99, "cyanosis": 4.15, "cystitis haemorrhagic": 5.81, "defaecation urgency": 13.37, "dermatitis contact": 10.57, "drug dependence": 2.62, "drug hypersensitivity": 5.99, "drug ineffective": 2.55, "drug ineffective for unapproved indication": 3.11, "drug interaction": 3.86, "dysphonia": 5.62, "dyspnoea": 2.91, "dyspnoea exertional": 2.02, "ear pruritus": 43.74, "emphysema": 6.39, "eosinophil count increased": 16.69, "eosinophilia": 17.85, "eosinophilic granulomatosis with polyangiitis": 18.3, "eye pruritus": 7.3, "faecal calprotectin increased": 19.26, "female genital tract fistula": 92.79, "foetal exposure during pregnancy": 3.09, "frequent bowel movements": 18.31, "full blood count abnormal": 32.97, "fungal infection": 3.36, "gastrooesophageal reflux disease": 6.87, "graft versus host disease": 3.37, "graft versus host disease in gastrointestinal tract": 26.69, "graft versus host disease in skin": 19.93, "growth retardation": 41.28, "haematochezia": 5.28, "haemoptysis": 2.35, "hypoxia": 2.87, "ill-defined disorder": 3.91, "impaired quality of life": 4.71, "infusion related reaction": 3.65, "intentional product misuse": 2.15, "lacrimation increased": 5.09, "laryngeal oedema": 3.64, "laryngeal stenosis": 299.69, "liver function test increased": 2.22, "loss of personal independence in daily activities": 9.45, "lower respiratory tract infection": 2.42, "lung diffusion test abnormal": 604.86, "lung disorder": 4.2, "lung opacity": 8.55, "macular degeneration": 21.82, "middle insomnia": 9.63, "nasal congestion": 4.22, "nasal obstruction": 13.4, "nasal polyps": 74.57, "obstructive airways disorder": 51.07, "oral candidiasis": 17.11, "oxygen saturation decreased": 2.02, "paraesthesia oral": 3.0, "pharyngitis streptococcal": 11.21, "platelet count increased": 11.26, "pleuritic pain": 7.72, "pneumothorax": 2.33, "premature baby": 3.07, "procedural pain": 21.82, "proctitis": 55.79, "product use in unapproved indication": 4.81, "product use issue": 2.03, "productive cough": 3.91, "pulmonary fibrosis": 5.14, "pulmonary function test abnormal": 125.37, "pulmonary mass": 5.3, "radiculopathy": 27.1, "rales": 12.55, "rectal haemorrhage": 3.22, "respiratory syncytial virus infection": 5.88, "rhinitis allergic": 28.36, "rhinorrhoea": 2.68, "secretion discharge": 5.23, "sinus disorder": 18.56, "sinusitis": 3.7, "sinusitis fungal": 60.09, "skin lesion": 5.05, "sleep disorder due to a general medical condition": 60.93, "sneezing": 6.75, "sputum discoloured": 9.0, "stenotrophomonas infection": 33.92, "systemic mycosis": 56.15, "tachypnoea": 11.3, "therapeutic product effect decreased": 2.53, "therapeutic product effect incomplete": 10.9, "throat clearing": 18.82, "treatment failure": 3.57, "treatment noncompliance": 2.08, "tuberculosis": 3.21, "type 2 diabetes mellitus": 7.16, "type iv hypersensitivity reaction": 12.04, "upper respiratory fungal infection": 434.68, "upper-airway cough syndrome": 60.41, "vaginal discharge": 15.12, "vaginal flatulence": 372.5, "vasculitis": 6.59, "vocal cord dysfunction": 187.33, "wheezing": 21.02}